Loading…

Vertex Pharmaceuticals (VRTX) Stock Analysis | GoodMoat

VRTX

VRTX

Vertex Pharmaceuticals

Stock Profile · Market Cap $126.79B

Current Price

$499.17

+8.31%

GoodMoat Value

$257.59

48.4% overvalued

P/E32.58

EPS$15.32

Beta0.32

P/B6.79

EV/EBITDA23.12

Div Yield—

Did you know?

With a beta of 0.32, it's less volatile than the overall market.

VRTX Price Chart

Market Cap$126.79B

Current Price$499.17

P/E Ratio32.58

Forward P/E24.21

PEG Ratio2.40

EPS$15.32

Book Value$73.49

P/B Ratio6.79

FCF vs CAPEX

Cash vs Debt

Net Cash: 3.2B

Revenue

2.6B

FY24

2.8B

FY24

11.0B

FY24

2.8B

FY25

3.0B

FY25

3.1B

FY25

12.0B

FY25

Net Income

—

FY24

1.0B

FY24

—

FY24

646M

FY25

1.0B

FY25

1.1B

FY25

4.0B

FY25

52-Week Range

$362.50

$519.68

50-Day MA: $468.21200-Day MA: $437.56

Did you know?

Price sits at 87% of its 52-week range.